Fast Track Designation was granted for BB-301 following FDA review of positive interim clinical study results and proprietary Responder Analysis planned for use in pivotal study for BB-301 BB-301 has ...
MedPage Today on MSN
Novel Oral miR-124 Enhancer Improves Remission in Refractory UC
P HOENIX -- A first-in-class oral miR-124 enhancer significantly improved clinical remission and endoscopic outcomes for ...
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming events: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback